40 new cases of measles reported in Texas as outbreak grows to 198: Officials
Antonio Perez/Chicago Tribune/Tribune News Service via Getty Images
(GAINES COUNTY, Texas) — The number of measles cases associated with an outbreak in western Texas has grown to 198, with 40 cases reported over the last three days, according to new data released Friday.
Almost all of the cases are in unvaccinated individuals or in individuals whose vaccination status is unknown, with 80 unvaccinated and 113 of unknown status. At least 23 people have been hospitalized so far, according to the Texas Department of State Health Services (DSHS).
Just five cases have occurred in people vaccinated with one dose of the measles, mumps, rubella (MMR) vaccine.
Children and teenagers between ages 5 and 17 make up the majority of cases, followed by children ages 4 and under.
The Texas death was the first measles death recorded in the U.S. in a decade, according to data from the Centers for Disease Control and Prevention.
A possible second measles death was recorded on Thursday after an unvaccinated New Mexico resident tested positive for the virus. The New Mexico Department of Health said the official cause of death is still under investigation.
Gaines County is the epicenter of the outbreak, with 137 cases confirmed among residents, according to DSHS. More than 90% of cases have been identified in just six counties, which account for less than 1% of the state’s total population, the department said.
State health data shows the number of vaccine exemptions in Gaines County have grown dramatically.
Roughly 7.5% of kindergarteners in the county had parents or guardians who filed for an exemption for at least one vaccine in 2013. Ten years later, that number rose to more than 17.5% — one of the highest in all of Texas, according to state health data.
The CDC has separately confirmed 164 cases in nine states so far this year in Alaska, California, Georgia, Kentucky, New Jersey, New Mexico, New York, Rhode Island and Texas.
The total, however, is likely an undercount due to delays in reporting from states to the federal government.
The majority of nationally confirmed cases are in people who are unvaccinated or whose vaccination status is unknown. Of the cases, 3% are among those who received one dose of the MMR shot and 2% are among those who received two doses.
Measles is one of the most contagious diseases known to humans. Just one infected patient can spread measles to up to nine out of 10 susceptible close contacts, according to the CDC.
Health officials have been urging anyone who isn’t vaccinated to receive the MMR vaccine.
The CDC currently recommends that people receive two vaccine doses, the first at ages 12 to 15 months and the second between 4 and 6 years old. One dose is 93% effective, and two doses are 97% effective. Most vaccinated adults don’t need a booster.
Texas health officials are recommending — for those living in the outbreak area — that parents consider an early dose of MMR vaccine for children between ages 6 months and 11 months and that adults receive a second MMR dose if they only received one in the past.
Earlier this week, the CDC said in a post on X that it was on the ground in Texas, partnering with DSHS officials to respond to the measles outbreak.
Measles was declared eliminated from the U.S. in 2000 due to the highly effective vaccination program, according to the CDC. However, CDC data shows vaccination rates have been lagging in recent years.
ABC News’ Youri Benadjaoud contributed to this report.
(WASHINGTON) — Tuesday marks five years since the World Health Organization (WHO) declared the global outbreak of COVID-19 to be a pandemic.
Since then, millions of Americans have been hospitalized, and more than 1.2 million people have died.
Additionally, millions of adults and children are still feeling the effects of their illness and have been diagnosed with long COVID.
Here’s a look at the disease in the U.S. by the numbers.
Hospitalizations
In the last 28 days, ending about Feb. 16, 2025, about 3,800 Americans were hospitalized due to COVID-19, according to data from the WHO.
During the week ending Feb. 22, the most recent week for which data is available, data from the Centers for Disease Control and Prevention (CDC) shows that just 1.3% of inpatient beds were occupied by COVID-19 patients as well as 1.3% of intensive care unit beds.
Additionally, during the week ending March 1, the rate of COVID-19-associated hospitalizations was 1.4 per 100,000 people. The peak for the 2024-25 season was 4.2 per 100,000 people during the week ending Jan. 4, which is much lower than the peak of 35.6 per 100,000 people during the 2021-22 season.
Deaths
Since the pandemic began, more than 1.22 million Americans have died from COVID-19 as of March 6, 2025, according to the latest CDC data. The U.S. crossed the 1 million mark on May 12, 2022.
During the week ending March 1, there were 274 deaths recorded from COVID, according to CDC provisional data. This is the lowest number recorded since the pandemic began.
Meanwhile, the age-adjusted death rate currently sits at 0.1 per 100,000 people, which has remained relatively consistent since spring 2024 and is among the lowest rates recorded since the pandemic.
By comparison, during the height of the omicron wave in winter 2021-22, the death rate was 53 times higher at 5.3 per 100,000. The highest-ever death rate was recorded the week ending Jan. 9, 2021, at 6.5 per 100,000.
Studies have suggested COVID-19 vaccines, combined with mitigation measures, helped save hundreds of thousands of lives in the U.S.
Long COVID
Long COVID is a condition that occurs when someone infected with COVID-19 is within three months of the initial diagnosis and lasts at least two months.
As of August 2024, a federal survey found that 17.9% of adults have experienced long COVID — equivalent to about 47.6 million Americans, according to 2024 U.S. Census Bureau estimates.
Meanwhile, 5.3% of adults — equivalent to about 14.1 million Americans — reported they were currently experiencing long COVID symptoms at the time of the survey. Of those currently experiencing long COVID, nearly a quarter said they had significant activity limitations.
Another recent federal study, published in the journal JAMA Pediatrics in February, showed approximately 1.01 million children, or 1.4%, are believed to have ever experienced long COVID as of 2023 and about 293,000, or 0.4%, were experiencing the condition when the survey was being conducted.
Vaccines
In June 2024, the CDC recommended that everyone ages 6 months and older receive an updated 2024-2025 COVID-19 vaccine to protect against severe illness, hospitalization and death.
The updated vaccines target the JN.1 lineage of the virus, an offshoot of the omicron variant. There are formulations from Pfizer-BioNTech and Moderna available for those 6 months old and older and from Novavax available for those aged 12 and older.
The CDC, however, has previously stated vaccination coverage remains low, meaning “many children and adults lack protection from respiratory virus infections provided by vaccines.”
As of Feb. 22, 2025, only 23.2% of adults and 11.9% of children were vaccinated with the updated vaccine, CDC data shows.
Additionally, despite evidence showing the vaccine is safe for pregnant women, the CDC estimates that just 13.8% of pregnant women have received the updated vaccine.
(NEW YORK) — As measles cases continue to spread across the United States, many Americans may be asking themselves if they need a measles vaccine booster to enhance protection.
An outbreak in western Texas has grown to 279 cases, mostly among those who are unvaccinated or whose vaccination status is unknown. Meanwhile, an outbreak in nearby New Mexico has also increased, reaching 38 cases as of Wednesday.
The Centers for Disease Control and Prevention (CDC) currently recommends that people receive two vaccine doses, the first at ages 12 to 15 months and the second between 4 and 6 years old. One dose is 93% effective, and two doses are 97% effective, the CDC says.
Most vaccinated adults don’t need another vaccine dose, said Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia. He also said it’s important to call another shot of the MMR vaccine “a dose” as opposed to a “booster.”
He explained that the measles vaccine used to be a single-dose vaccine before a second dose was recommended in the late 1980s.
“In the late ’80s, there were sort of big outbreaks of measles,” Offit told ABC News. “But if you looked at the epidemiology of those outbreaks, it was in people who never got a vaccine.”
He went on, “So it wasn’t that the immunity faded, that the vaccine wasn’t good enough. It’s an excellent vaccine as a single-dose vaccine. The problem was people didn’t get it. So, the second dose recommendation really was to give children a second chance to get a first dose.”
Depending on the year you were born
If someone was born before 1957, they are presumed to have life-long immunity against measles, Offit said.
Before the MMR vaccine was available, nearly everyone was infected with measles, mumps and rubella during childhood, according to the CDC.
Those with a confirmed laboratory diagnosis of measles are protected from the virus, the agency adds.
In 1963, the first measles vaccine became available, followed by an improved vaccine in 1968, said Dr. Gregory Poland, a vaccinologist and co-director of The Atria Research Institute — which focuses on disease prevention.
A very small number of people, representing less than 5% of Americans, may have received the inactivated measles vaccine from 1963 through 1967 during childhood, which may not have offered sufficient protection against the virus. These people would be eligible for re-vaccination with one or two doses, the CDC says.
“So, the first measles vaccine licensed in the U.S. was in 1963 and it was an inactivated vaccine,” he told ABC News. “That inactivated vaccine had two consequences to it. One, it did not produce protective immunity and, number two, it led to — when people did get exposed and infected — it led to atypical measles, and that can be very severe.”
Poland said, at the time, there was also a live attenuated measles vaccine, similar to what is used today “but it was not very attenuated or weakened, and so it caused a lot of side effects.”
He explained that to decrease side effects, physicians would give a patient a vaccine and then a shot of immunoglobulin, or antibodies. While this decreased side effects, it also tended to kill the vaccine virus, not giving people adequate immunity.
For those who were vaccinated with the single-dose vaccine similar to the one used today — or received the MMR vaccine — Offit said another dose is likely not needed.
In 1989, the Advisory Committee on Immunization Practices, the American Academy of Pediatrics and the American Academy of Family Physicians recommended children receive a second MMR dose.
Offit and Poland said anyone who has received two doses of the MMR vaccine does not need to receive another dose.
If someone is unsure if they are immune to measles, they should first try to find their vaccination records. If they cannot find written documentation, there is generally no harm in receiving another dose of the MMR vaccine, according to the CDC. A health care provider can also test blood to determine whether someone is immune, but this is generally not recommended.
In the face of the growing measles outbreak, the CDC issued an alert on March 7 saying parents in the outbreak area should consider getting their children an early third dose of the MMR vaccine.
Texas health officials have also recommended early vaccination for infants living in outbreak areas.
This would result in three doses overall: an early dose between age 6 months and 11 months and then the two regularly scheduled doses.
Poland says it’s important to note that this dose is only for infants living in high-risk areas or going to visit high-risk areas and not recommended for most children.
“Generally, the reason we don’t give [the vaccine] at an early age is that, if the mother was immunized or had disease, the antibodies that she has are passed through the placenta to the baby — those last around 12 months,” he said. “If you give the vaccine prior to that, then some amount of that live virus vaccine will be killed by the mother’s antibodies circulating in the baby, and so it’s not long-lasting, high-titer immunity.”
(NEW YORK) — Dr. Kimberly Shriner remembers the first COVID-19 patient who came into Huntington Hospital in Pasadena, California, in March 2020.
He was a 35-year-old man who arrived at the hospital short of breath.
“He went straight to our intensive care unit. We were very suspicious that he had COVID,” Shriner, an infectious disease specialist and the hospital’s medical director of infectious disease and infection prevention, told ABC News.
Testing was minimal at the time, but eventually the results came back and confirmed that he had COVID. The patient was eventually sedated and intubated, and he died 24 hours later. Shriner said the next few patients admitted to the hospital for COVID-19 followed similar trajectories, becoming more and more short of breath before eventually dying of their illness.
“As physicians, we understand death,” Shriner said. “We understand that we can’t save every patient, but when you’re having 100% mortality with your first experience with this thing, it was pretty overwhelming and daunting. That first week [was] particularly surreal.”
Tuesday, March 11, marked five years since the World Health Organization (WHO) declared the global outbreak of COVID-19 to be a pandemic. The U.S. is in a much better situation now, with fewer hospitalizations and deaths — and vaccines to prevent severe illness from COVID, frontline health care workers say.
However, they add that, as Americans become more removed from the early days of COVID, it may be hard to remember what it was like — especially for those who were treating patients.
“Everybody was worried, doctors, nurses,” Dr. Matthew Sims, director of infectious disease research for Corewell Health, a non-profit health care system located in Michigan, told ABC News. “It was absolutely crazy, and I think that people have forgotten. I think people have forgotten the horror of what COVID was like in the beginning and, I mean, it was a horror situation.”
Quickly changing world
Shriner said one of the indicators of how quickly the world was changing was the evolution of her hospital’s meetings about the virus and how to prepare as information was starting to come out of China.
“Meetings were held in a very tiny, little meeting room. Nobody was wearing masks or anything,” she said. “And then as things began to evolve, and we saw it was happening, that the rooms got started getting bigger, and then we started meeting with masks on, and then, eventually, went virtual.”
Shriver recalled that the situation was “very terrifying” on a personal and professional level.
“If we’d known how difficult it was going to be, I think we would have been even more disturbed,” she said.
Sims said it became clear how quickly patients could get infected in March 2020. Not long after the WHO declared a global pandemic, he came on shift that week to be the infectious disease doctor rotating in the hospital.
“We had two confirmed cases admitted at that point. By the end of the week I spent on, we had over 100 confirmed cases admitted,” he told ABC News. “It was absolutely devastating to the hospital, to the health care system as a whole … It was a crazy time.”
The state of hospitals
Both Sims and Shriner said the lack of early testing at the time was a source of frustration. Since routine testing wasn’t available, results often took days — or even weeks — to return.
Additionally, hospital labs often had to confirm results with state departments of health.
Sim said as the hospitals became full, it sometimes became a race against the clock to try and treat patients.
“I remember one of the most devastating cases I saw was a young man, relatively young, young kids at home,” he said. “A little overweight, I think he was a diabetic, but he just got super sick, and we were trying to get remdesivir, which was compassionate use at the time,” referencing an antiviral drug later approved to treat COVID-19.
Sims said the hospital had to call up the company manufacturing the drug, tell them about the patient and then get approval from the U.S. Food and Drug Administration (FDA) to use doses on the patient.
“And we got approval, and then they have to ship it to us,” Sims said. “It was all being shipped as fast as possible, but before it could even get here, that patient got too sick to even use it, and the patient died. A week before, he was home with his kids, his wife, et cetera, in normal state of health, and then, all of a sudden, got this terrible virus and died.”
As it became clear how contagious the virus was, hospital staff were required to always wear masks. Shriner said she still has a scar or imprint on her nose from having to wear a mask for 18 hours a day.
One of things she remembers most was the lack of sound, other than machines, whenever she visited ICUs.
“As the months progressed, we ended up having six different intensive care units because the patients were so sick,” she said. “We had many, many patients that were on ventilators. You’d walk into these areas, and it was just silence. All you heard were the ventilators going and seeing people in full protective gear all the time.”
To handle the influx of patients, both hospitalized and in emergency departments, Shriner said her hospital stopped all non-emergency surgeries to be able to have extra physicians available.
COVID-19 vaccines arrive
On Dec. 11, 2020, the FDA granted Pfizer-BioNTech the first emergency use authorization for a COVID-19 vaccine for those aged 16 and older. Three days later, nurse Sandra Lindsay became the first person to receive a COVID-19 vaccine in the U.S. as distribution began.
Both Shriner and Sims felt a sense of relief that a tool was finally available to help stem the spread of disease.
Shriner said she was the first person in her hospital to receive the COVID-19 vaccine, even though she didn’t want to be.
“I didn’t want to be the first person. I was perfectly fine with letting other people go ahead of me,” she said. “And [the CEO] said to me, ‘You have to be.’ She said, ‘If you don’t get vaccinated, nobody else is going to do it.'”
Shriner said the distribution of the vaccine “was a sign of the way out. It was very hopeful.”
Lessons learned
Both Sims and Shriner say COVID-19 taught health care workers many lessons, including how to share information quickly, how to diligently monitor diseases and how to scale up health care capacity.
Sims said another valuable discovery was better communicating to the public that information during a public health crisis can change rapidly.
One example is that early studies would come out suggesting certain drugs might help treat patients. Eventually additional information would be published proving the opposite.
“We were learning, and we were learning in such a rapid [way], it was hard to communicate,” he said. “I think if we had any failure, it was that in that rapid push to communicate.”
Sims noted how that created some uncertainty.
“We didn’t get the message across enough that some of what we’re learning may be wrong, and we will tell you that as we learn,” Sims said. “We’re going to tell you what we know now that may not be the same thing we know tomorrow.”
Shriner added that stay-at home orders and lockdowns were hard on people and, if another pandemic happens, she is hopeful there would be different decisions on what should be locked down.
“Maybe we don’t have such stringent lockdown rules and isolation rules,” she said. “You know, the outdoor restaurant became a great thing. You know, think of all the home delivery services really took off. And so, a lot of good things came out of it, but they were hard won.”
